Drugs / Cat hair
Cat hair
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01711593 | Jan 2013 → Sep 2016 | allergic disease, asthma | Andrew D. Luster, M.D.,Ph.D. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT01292070 Background | Mar → Apr 2011 | — | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00689299 Comparator | Oct 2008 → May 2009 | allergic disease | Antigen Laboratories, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cat hair | “1)Cat hair” NCT01711593 ↗ |
| Known as | CAT | “Positive Control - standardized cat hair allergenic extract (CAT)” NCT01292070 ↗ |
| Known as | Standardized Allergenic Extract, Cat Hair | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00689299 ↗ |
| Known as | standardized cat hair allergenic extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01292070 ↗ |